Par Health Brevital Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP)
Brevital Sodium 500 mg/vial CIV contains particulate matter that can cause life-threatening adverse health consequences.
2 photos
What happened
Par Health is voluntarily recalling two lots of Brevital Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level due to the presence of particulate matter identified as cellulose. Administration of the product may cause life-threatening adverse health consequences including pulmonary emboli, occlusions of other blood vessels, and inflammation of the walls of veins. To date, Par Health has not received any reports of adverse events related to this recall.
The recalled lots were distributed nationwide to wholesalers between July 8, 2025 and May 11, 2026. Par Health is providing written notification to wholesale accounts and arranging for return of all existing inventory through Inmar, Inc. Wholesale distributors and hospital pharmacies that have the product should immediately discontinue use and stop distribution.
Summary by Recall Canary from the FDA notice.
What to do
If a code on your package matches:
- Par Health is providing written notification to wholesale accounts that have received the affected lots and are arranging for return of all existing inventory of Lots 86930 and 88623 through Inmar, Inc. Wholesale distributors and hospital pharmacies that have the product being recalled should immediately discontinue use and stop distribution.
- If you have further distributed the recalled product, please notify your accounts or any additional locations which may have received the recalled product.
- Questions regarding this recall can be directed to Inmar, Inc. at 1-844-774-1187 Monday through Friday between the hours of 9 a.m. and 5 p.m. ET or by email at rxrecalls@
inmar.com. - For medical or technical product information or to report a product complaint or adverse event please call 1-800-828-9393 Monday through Thursday between the hours of 9 a.m. and 8 p.m. ET or Friday between 9 a.m. and 6 p.m. ET.
Is yours affected?
Match your product and all the details in one listed combination.
Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP), Distributed by: Par Pharmaceutical*
- Size
- 42023-105-01
- Item number
- 86930
- Lot code
- 02/2028
- Item number
- 88623
- Lot code
- 04/2028
Details
- Company announced
- Sold in
These lots were distributed nationwide to wholesalers between July 8, 2025 and May 11, 2026.
- Company
- Par Health
- Hazard
- Foreign material
